Phase II study of oral S-1 plus irinotecan in patients with advanced colorectal cancer: Hokkaido Gastrointestinal Cancer Study Group HGCSG0302.
Komatsu Y, Yuuki S, Fuse N, Takei M, Kato T, Miyagishima T, Kudo M, Kunieda Y, Tateyama M, Wakahama O, Meguro T, Ohizumi H, Watanabe M, Akita H, Sakata Y, Asaka M.
Komatsu Y, et al. Among authors: yuuki s.
Jpn J Clin Oncol. 2005 Feb;35(2):88-9. doi: 10.1093/jjco/hyi025.
Jpn J Clin Oncol. 2005.
PMID: 15709093
Clinical Trial.